Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05092958 |
|---|---|
| Brief Title: | Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study |
| First Submitted : | October 22, 2021 |
| First Submitted that Met QC Criteria : | October 22, 2021 |
| First Posted : | October 26, 2021 |
| Last Update Submitted that Met QC Criteria : | April 3, 2024 |
| Last Update Posted : | April 4, 2024 |